ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER

Ph.D

Saved in:

Bibliographic Details
Main Author:	CHEN LUXI
Other Authors:	PHARMACOLOGY
Format:	Theses and Dissertations
Language:	English
Published:	2013
Subjects:	Annexin-A1, PPAR-gamma, TNBC, biomarker, chemotherapeutic target, RIP1
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/47507
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-47507
record_format	dspace
spelling	sg-nus-scholar.10635-475072015-09-23T19:45:53Z ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER CHEN LUXI PHARMACOLOGY ALAN PREM KUMAR LIM HSIU KIM, LINA Annexin-A1, PPAR-gamma, TNBC, biomarker, chemotherapeutic target, RIP1 Ph.D DOCTOR OF PHILOSOPHY 2013-11-09T18:00:25Z 2013-11-09T18:00:25Z 2013-01-22 Thesis CHEN LUXI (2013-01-22). ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER. ScholarBank@NUS Repository. http://scholarbank.nus.edu.sg/handle/10635/47507 NOT_IN_WOS en
institution	National University of Singapore
building	NUS Library
country	Singapore
collection	ScholarBank@NUS
language	English
topic	Annexin-A1, PPAR-gamma, TNBC, biomarker, chemotherapeutic target, RIP1
spellingShingle	Annexin-A1, PPAR-gamma, TNBC, biomarker, chemotherapeutic target, RIP1 CHEN LUXI ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
description	Ph.D
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY CHEN LUXI
format	Theses and Dissertations
author	CHEN LUXI
author_sort	CHEN LUXI
title	ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
title_short	ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
title_full	ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
title_fullStr	ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
title_full_unstemmed	ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER
title_sort	annexin-a1, a novel biomarker predicts chemo-sensitivity to ppar-¿ agonist therapy in triple-negative breast cancer
publishDate	2013
url	http://scholarbank.nus.edu.sg/handle/10635/47507
_version_	1681083367261470720

ANNEXIN-A1, A NOVEL BIOMARKER PREDICTS CHEMO-SENSITIVITY TO PPAR-¿ AGONIST THERAPY IN TRIPLE-NEGATIVE BREAST CANCER

Similar Items